Cargando…
Aspirin for primary prevention: Is this the end of the road?
Aspirin is one of the oldest and most commonly used cardiovascular drugs. Despite there being high-quality evidence supporting the use of aspirin for patients with known cardiovascular disease, a definitive consensus regarding its use for patients at risk for cardiovascular disease (and without esta...
Autores principales: | Singal, Aayush Kumar, Karthikeyan, Ganesan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620426/ https://www.ncbi.nlm.nih.gov/pubmed/31280821 http://dx.doi.org/10.1016/j.ihj.2019.04.001 |
Ejemplares similares
-
The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta
por: Walsh, Scott W., et al.
Publicado: (2021) -
Aspirin for Primary Prevention of Cardiovascular Disease
por: Kim, Ji Hye, et al.
Publicado: (2019) -
Aspirin for primary prevention of cardiovascular disease
por: Nansseu, Jobert Richie N., et al.
Publicado: (2015) -
Use and Misuse of Aspirin in Primary Cardiovascular Prevention
por: Coccheri, Sergio
Publicado: (2017) -
Detecting sub-clinical disease activity in patients with chronic rheumatic valvular heart disease
por: Singal, Aayush Kumar, et al.
Publicado: (2021)